TRYPF
Price:
$0.0562
Market Cap:
$7.53M
Tryp Therapeutics Inc., a pharmaceutical company, focuses on identifying and developing compounds for diseases with high unmet medical needs. The company's lead development program is (PFN), which is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin. Its PFN program candidates include TRP-8802 and TRP-8803 for fibromyalgia, phantom limb pain, binge eating disorder, complex regional pain syndrome, and hypothalamic obesity. The company has an agreement with the Calvert Labs to design and execute exploratory studies related to psilocybin-for-neuropsychiatric disorders program; and a service agreement with Fluence to provide design and traini...[Read more]
Industry
Biotechnology
IPO Date
2021-02-08
Stock Exchange
PNK
Ticker
TRYPF
According to Tryp Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.55M. This represents a change of 19.05% compared to the average of 6.34M of the last 4 quarters.
The mean historical Enterprise Value of Tryp Therapeutics Inc. over the last ten years is 21.46M. The current 7.55M Enterprise Value has changed 3.42% with respect to the historical average. Over the past ten years (40 quarters), TRYPF's Enterprise Value was at its highest in in the November 2020 quarter at 66.87M. The Enterprise Value was at its lowest in in the February 2024 quarter at 1.65M.
Average
21.46M
Median
19.53M
Minimum
8.31M
Maximum
38.48M
Discovering the peaks and valleys of Tryp Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 38.48M
Minimum Annual Increase = -55.37%
Minimum Annual Enterprise Value = 8.31M
Year | Enterprise Value | Change |
---|---|---|
2023 | 8.31M | -31.06% |
2022 | 12.05M | -55.37% |
2021 | 27.00M | -29.82% |
The current Enterprise Value of Tryp Therapeutics Inc. (TRYPF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
15.79M
5-year avg
21.46M
10-year avg
21.46M
Tryp Therapeutics Inc.’s Enterprise Value is less than PsyBio Therapeutics Corp. (0), greater than PharmaTher Holdings Ltd. (435.39K), less than Awakn Life Sciences Corp. (19.03M), greater than SanBio Company Limited (3.92M), less than Alterity Therapeutics Limited (36.91B), less than Amplia Therapeutics Limited (16.58M), less than Adynxx, Inc. (56.46M), greater than Sosei Group Corporation (581.00), less than Biostage, Inc. (126.28B), less than Antibe Therapeutics Inc. (57.66M), greater than America Great Health (4.58M), less than Cellectis S.A. (12.38M), less than Biotron Limited (144.28M), less than Regenicin, Inc. (19.46M), greater than AXIM Biotechnologies, Inc. (15.35K), less than Bioasis Technologies Inc. (7.85M), less than Nova Mentis Life Science Corp. (39.53M), greater than HAVN Life Sciences Inc. (1.18M), greater than null (767.21K),
Company | Enterprise Value | Market cap |
---|---|---|
0 | $300.75K | |
435.39K | $15.23M | |
19.03M | $3.33M | |
3.92M | $264.22M | |
36.91B | $19.15M | |
16.58M | $38.41M | |
56.46M | $581.00 | |
581.00 | $696.73M | |
126.28B | $57.82M | |
57.66M | $11.45M | |
4.58M | $10.59M | |
12.38M | $183.12M | |
144.28M | $13.08M | |
19.46M | $15.35K | |
15.35K | $1.45M | |
7.85M | $28.44M | |
39.53M | $815.75K | |
1.18M | $551.95K | |
767.21K | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tryp Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tryp Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Tryp Therapeutics Inc.'s Enterprise Value?
What is the highest Enterprise Value for Tryp Therapeutics Inc. (TRYPF)?
What is the 3-year average Enterprise Value for Tryp Therapeutics Inc. (TRYPF)?
What is the 5-year average Enterprise Value for Tryp Therapeutics Inc. (TRYPF)?
How does the current Enterprise Value for Tryp Therapeutics Inc. (TRYPF) compare to its historical average?